APA (7th ed.) Citation

PA, V., KS, M., WT, H., GG, S., SL, C., L, O., . . . BN, F. (2017). The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism. Experimental physiology, 102(8), 985. https://doi.org/10.1113/EP086380

Chicago Style (17th ed.) Citation

PA, Vigueira, et al. "The Beneficial Metabolic Effects of Insulin Sensitizers Are Not Attenuated by Mitochondrial Pyruvate Carrier 2 Hypomorphism." Experimental Physiology 102, no. 8 (2017): 985. https://doi.org/10.1113/EP086380.

MLA (9th ed.) Citation

PA, Vigueira, et al. "The Beneficial Metabolic Effects of Insulin Sensitizers Are Not Attenuated by Mitochondrial Pyruvate Carrier 2 Hypomorphism." Experimental Physiology, vol. 102, no. 8, 2017, p. 985, https://doi.org/10.1113/EP086380.